Search results
Results from the WOW.Com Content Network
FDA inspectors identified the issues at Neuralink's animal testing facilities in California in June 2023, several weeks after the agency had given the company the green light for a small study of ...
A similar inspection at Neuralink's Texas facility did not find problems, according to agency records. Those visits took place last year from June 12-22, and represent the FDA's sole inspections ...
The agency also said it routinely carries out inspections after a human trial is approved. When it inspected Neuralink, the FDA said it did not find violations that would undermine the safety of ...
Neuralink received FDA approval for human clinical trials in May 2023. [90] The FDA had rejected a 2022 application to pursue human clinical trials, citing "major safety concerns involving the device's lithium battery; the potential for the implant's tiny wires to migrate to other areas of the brain; and questions over whether and how the ...
On January 5, 2007, the U.S. Food and Drug Administration (FDA) approved Slentrol, the first time the FDA has approved a drug for obese dogs. [3] [4]However, concerns have since been raised, since 2010, about adverse effects [5] that might more strongly affect particular breeds.
The investigation has come at a time of growing employee dissent about Neuralink’s animal testing, including complaints that pressure from CEO Musk to accelerate development has resulted in ...
While it is currently only FDA-approved for dogs and horses, PSGAG is also used off-label to treat lameness in swine, as a chondroprotectant ("joint protector") or treatment of interstitial cystitis in cats, and to treat arthritis in rabbits. [1] [3] [9]
Neuralink, Elon Musk’s medical implant company, is facing a federal probe over possible animal welfare violations, according to a report from Reuters. The investigation, reportedly opened by the ...